Literature DB >> 23800672

Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.

C van Laar1, M J C van der Sangen, P M P Poortmans, G A P Nieuwenhuijzen, J A Roukema, R M H Roumen, V C G Tjan-Heijnen, A C Voogd.   

Abstract

AIM: To evaluate trends in the risk of local recurrences after breast-conserving treatment (BCT) and to examine the impact of local recurrence (LR) on distant relapse-free survival in a large, population-based cohort of women aged ≤40 years with early-stage breast cancer.
METHODS: All women (n=1143) aged ≤40 years with early-stage (pT1-2/cT1-2, N0-2, M0) breast cancer who underwent BCT in the south of the Netherlands between 1988 and 2010 were included. BCT consisted of local excision of the tumour followed by irradiation of the breast.
RESULTS: After a median follow-up of 8.5 (0.1-24.6)years, 176 patients had developed an isolated LR. The 5-year LR-rate for the subgroups treated in the periods 1988-1998, 1999-2005 and 2006-2010 were 9.8% (95% confidence interval (CI) 7.1-12.5), 5.9% (95% CI 3.2-8.6) and 3.3% (95% CI 0.6-6.0), respectively (p=0.006). In a multivariate analysis, adjuvant systemic treatment was associated with a reduced risk of LR of almost 60% (hazard ratio (HR) 0.42; 95%CI 0.28-0.60; p<0.0001). Patients who experienced an early isolated LR (≤5 years after BCT) had a worse distant relapse-free survival compared to patients without an early LR (HR 1.83; 95% CI 1.27-2.64; p=0.001). Late local recurrences did not negatively affect distant relapse-free survival (HR 1.24; 95% CI 0.74-2.08; p=0.407).
CONCLUSION: Local control after BCT improved significantly over time and appeared to be closely related to the increased use and effectiveness of systemic therapy. These recent results underline the safety of BCT for young women with early-stage breast cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast carcinoma; Breast-conservation; Local recurrence; Prognosis; Risk; Young age

Mesh:

Year:  2013        PMID: 23800672     DOI: 10.1016/j.ejca.2013.05.030

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery.

Authors:  Gianluca Vanni; Marco Materazzo; Marco Pellicciaro; Ljuba Morando; Ilaria Portarena; Lucia Anemona; Maria Rolando D'Angelillo; Rosaria Barbarino; Agostino Chiaravalloti; Rosaria Meucci; Tommaso Perretta; Camilla Deiana; Paolo Orsaria; Jonathan Caspi; Chiara Adriana Pistolese; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

3.  Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Authors:  James Laird; Benjamin Lok; Chun Siu; Oren Cahlon; Atif J Khan; Beryl McCormick; Simon N Powell; Hiram Cody; Hannah Yong Wen; Alice Ho; Lior Z Braunstein
Journal:  Ann Surg Oncol       Date:  2017-11-01       Impact factor: 5.344

Review 4.  Breast cancer under age 40: a different approach.

Authors:  D Ribnikar; J M Ribeiro; D Pinto; B Sousa; A C Pinto; E Gomes; E C Moser; M J Cardoso; F Cardoso
Journal:  Curr Treat Options Oncol       Date:  2015-04

5.  Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.

Authors:  Julia C Radosa; Anne Eaton; Michelle Stempel; Amrin Khander; Cornelia Liedtke; Erich-Franz Solomayer; Maria Karsten; Melissa Pilewskie; Monica Morrow; Tari A King
Journal:  Ann Surg Oncol       Date:  2016-10-25       Impact factor: 5.344

6.  Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.

Authors:  Francesca Arcadipane; Pierfrancesco Franco; Chiara De Colle; Nadia Rondi; Jacopo Di Muzio; Emanuela Pelle; Stefania Martini; Ada Ala; Mario Airoldi; Michela Donadio; Corrado De Sanctis; Isabella Castellano; Riccardo Ragona; Umberto Ricardi
Journal:  Med Oncol       Date:  2016-08-29       Impact factor: 3.064

7.  Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.

Authors:  A Kümmel; S Kümmel; J Barinoff; F Heitz; J Holtschmidt; W Weikel; F Lorenz-Salehi; A du Bois; P Harter; A Traut; J U Blohmer; B Ataseven
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-07       Impact factor: 2.915

8.  Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.

Authors:  Willemina R R Geurts-Giele; Victorien M T van Verschuer; Carolien H M van Deurzen; Paul J van Diest; Rute M S M Pedrosa; J Margriet Collée; Linetta B Koppert; Caroline Seynaeve; Winand N M Dinjens
Journal:  Mod Pathol       Date:  2016-09-09       Impact factor: 7.842

Review 9.  Current Treatment of Isolated Locoregional Breast Cancer Recurrences.

Authors:  Wolfgang Harms; Andreas Geretschläger; Corinne Cescato; Martin Buess; Dieter Köberle; Branca Asadpour
Journal:  Breast Care (Basel)       Date:  2015-08-21       Impact factor: 2.860

10.  Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone.

Authors:  Dang Van Nguyen; Sang-Won Kim; Young-Taek Oh; O Kyu Noh; Yongsik Jung; Mison Chun; Dae Sung Yoon
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.